TrialWorld journal of critical care medicine2025

Efficacy and safety of exosomes from Wharton's Jelly-derived mesenchymal stem cells in traumatic brain injury.

Serdar Kabatas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.